ESC Premium Access

Poster Session 3 - Atrial fibrillation - Stroke prevention - General

Event: ESC Congress 2018
Topic: European Society of Cardiology, Other
Session type: Poster Session
Date: 26 August 2018

Congress Session

9 presentations in this session

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation: a propensity-weighted cohort study

Speaker: Associate Professor E. Grove (Aarhus, DK)
Thumbnail

Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF prospective registry

Speaker: Ms K. Pieper (London, GB)
Thumbnail

Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

Impact of age > 75 years on one-year events in patients with atrial fibrillation and left atrial appendage occluder implantation. Results of the prospective LAARGE Registry

Speaker: Professor U. Zeymer (Ludwigshafen, DE)
Thumbnail

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study

Speaker: Doctor X. Li (Princeton, NJ, US)
Thumbnail

Stroke, thromboembolism and bleeding events in patients with atrial fibrillation according to the new EHRA valvular heart disease classification

Speaker: Doctor A. Bisson (Tours, FR)
Thumbnail

Self-reported physical activity is associated with biomarkers of cardiac fibrosis and cell apoptosis in patients with atrial fibrillation

Speaker: Associate Professor M. Dzeshka (Grodno, BY)
Thumbnail

No impact of atrial fibrillation on sleep quality and sleep duration in patients with sleep-disordered breathing and preserved ejection fraction

Speaker: Doctor F. Roder (Bad Oeynhausen, DE)
Thumbnail

Association of circulating apoptotic (annexin V+) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction

Speaker: Associate Professor M. Dzeshka (Grodno, BY)
Thumbnail

9 speakers from this session

Associate Professor Erik Lerkevang Grove

Aarhus University Hospital, Aarhus (Denmark)
0 follower

Ms Karen Pieper

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
3 followers

Professor Uwe Zeymer

Klinikum Ludwigshafen, Ludwigshafen (Germany)
13 presentations
0 follower

Doctor Xiaoyan Li

Bristol Myers-Squibb, Princeton, NJ (United States of America)
0 follower

Doctor Arnaud Bisson

CHU de Tours, Tours (France)
0 follower

Associate Professor Mikhail Dzeshka

Grodno State Medical University, Grodno (Belarus)
0 follower

Doctor Fabian Roder

Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen (Germany)
0 follower

Associate Professor Mikhail Dzeshka

Grodno State Medical University, Grodno (Belarus)
0 follower

This platform is supported by

logo Novo Nordisk